晚期卵巢癌复诊剖腹手术的结果:单中心经验。

ISRN obstetrics and gynecology Pub Date : 2012-01-01 Epub Date: 2012-10-16 DOI:10.5402/2012/849518
Tarak Damak, Riadh Chargui, Jamel Ben Hassouna, Monia Hechiche, Khaled Rahal
{"title":"晚期卵巢癌复诊剖腹手术的结果:单中心经验。","authors":"Tarak Damak,&nbsp;Riadh Chargui,&nbsp;Jamel Ben Hassouna,&nbsp;Monia Hechiche,&nbsp;Khaled Rahal","doi":"10.5402/2012/849518","DOIUrl":null,"url":null,"abstract":"<p><p>Objective. The goal of the study was to analyse the results of 85 cases of second-look laparotomy (SLL) and explore the influence of this procedure on survival. Patients and Methods. We reviewed retrospectively 85 cases of SLL collected and treated in our institute between 1994 and 2003. Results. Complete pathologic response (CPR) was 25.8%, microscopic disease (Rmicro) was 38.8%, and macroscopic disease (Rmacro) was 35.4%. In patients with negative SLL results, disease recurrence was diagnosed in 41%. The 3- and 5-year overall survival rates for the entire population were 91% and 87%, respectively. The 3- and 5-year disease-free survivals were, respectively, 76.3% and 58.5% in negative SLL versus 55.7% and 16% in positive SLL. The difference between the group of patients with complete response (76%) and the patients with residual microscopic disease (72%) was not significant. The tumoral residuum after initial surgery was the only prognostic factor influencing significantly the disease-free survival. On Cox regression model analysis, only initial tumoral residuum (P = 0.04) and tumoral residuum after SLL (P = 0.02) were independent prognostic factors for survival. Conclusions. The most important advantage of SLL is the early detection of recurrence and thus the early administration of consolidation treatment resulting in a better prognosis.</p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/849518","citationCount":"8","resultStr":"{\"title\":\"Results of second-look laparotomy in advanced ovarian cancer: one single center experience.\",\"authors\":\"Tarak Damak,&nbsp;Riadh Chargui,&nbsp;Jamel Ben Hassouna,&nbsp;Monia Hechiche,&nbsp;Khaled Rahal\",\"doi\":\"10.5402/2012/849518\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Objective. The goal of the study was to analyse the results of 85 cases of second-look laparotomy (SLL) and explore the influence of this procedure on survival. Patients and Methods. We reviewed retrospectively 85 cases of SLL collected and treated in our institute between 1994 and 2003. Results. Complete pathologic response (CPR) was 25.8%, microscopic disease (Rmicro) was 38.8%, and macroscopic disease (Rmacro) was 35.4%. In patients with negative SLL results, disease recurrence was diagnosed in 41%. The 3- and 5-year overall survival rates for the entire population were 91% and 87%, respectively. The 3- and 5-year disease-free survivals were, respectively, 76.3% and 58.5% in negative SLL versus 55.7% and 16% in positive SLL. The difference between the group of patients with complete response (76%) and the patients with residual microscopic disease (72%) was not significant. The tumoral residuum after initial surgery was the only prognostic factor influencing significantly the disease-free survival. On Cox regression model analysis, only initial tumoral residuum (P = 0.04) and tumoral residuum after SLL (P = 0.02) were independent prognostic factors for survival. Conclusions. The most important advantage of SLL is the early detection of recurrence and thus the early administration of consolidation treatment resulting in a better prognosis.</p>\",\"PeriodicalId\":73520,\"journal\":{\"name\":\"ISRN obstetrics and gynecology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.5402/2012/849518\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ISRN obstetrics and gynecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5402/2012/849518\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/10/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN obstetrics and gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2012/849518","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/10/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

目标。本研究的目的是分析85例二次剖腹手术(SLL)的结果,并探讨该手术对生存的影响。患者和方法。我们回顾了1994年至2003年在我院收集和治疗的85例SLL病例。结果。完全病理反应(CPR)为25.8%,显微病变(Rmicro)为38.8%,宏观病变(Rmacro)为35.4%。在SLL结果阴性的患者中,41%的患者被诊断为疾病复发。整个人群的3年和5年生存率分别为91%和87%。SLL阴性组3年和5年无病生存率分别为76.3%和58.5%,而SLL阳性组为55.7%和16%。完全缓解组(76%)与残留显微病变组(72%)的差异无统计学意义。初次手术后肿瘤残留是唯一影响无病生存的预后因素。在Cox回归模型分析中,只有初始肿瘤残留(P = 0.04)和SLL后肿瘤残留(P = 0.02)是生存的独立预后因素。结论。SLL最重要的优势是早期发现复发,因此早期给予巩固治疗,预后较好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Results of second-look laparotomy in advanced ovarian cancer: one single center experience.

Results of second-look laparotomy in advanced ovarian cancer: one single center experience.

Results of second-look laparotomy in advanced ovarian cancer: one single center experience.

Objective. The goal of the study was to analyse the results of 85 cases of second-look laparotomy (SLL) and explore the influence of this procedure on survival. Patients and Methods. We reviewed retrospectively 85 cases of SLL collected and treated in our institute between 1994 and 2003. Results. Complete pathologic response (CPR) was 25.8%, microscopic disease (Rmicro) was 38.8%, and macroscopic disease (Rmacro) was 35.4%. In patients with negative SLL results, disease recurrence was diagnosed in 41%. The 3- and 5-year overall survival rates for the entire population were 91% and 87%, respectively. The 3- and 5-year disease-free survivals were, respectively, 76.3% and 58.5% in negative SLL versus 55.7% and 16% in positive SLL. The difference between the group of patients with complete response (76%) and the patients with residual microscopic disease (72%) was not significant. The tumoral residuum after initial surgery was the only prognostic factor influencing significantly the disease-free survival. On Cox regression model analysis, only initial tumoral residuum (P = 0.04) and tumoral residuum after SLL (P = 0.02) were independent prognostic factors for survival. Conclusions. The most important advantage of SLL is the early detection of recurrence and thus the early administration of consolidation treatment resulting in a better prognosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信